HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

David Straus, John Radford, Joseph Connors, Won Seog Kim, Andrea Gallamini, Radhakrishnan Ramchandren, Jonathan Friedberg, Ranjana Advani, Martin Hutchings, Andrew Evens, Piotr Smolewski, Kerry Savage, Nancy Bartlett, Hyeon Seok Eom, Jeremy Abramson, Cassie Dong, Frank Campana, Keenan Fenton, Markus Puhlmann, Stephen Ansell

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1'. Together they form a unique fingerprint.

Medicine & Life Sciences